← FDA Drug Approvals (Drugs@FDA)

SPRINTEC

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BARR · Approved 2002-09-25

Drug application

FDA Application #
ANDA075804
Application type
Abbreviated New Drug Application (Generic)
Brand name
SPRINTEC
Generic name
NORGESTIMATE AND ETHINYL ESTRADIOL
Active ingredients
ETHINYL ESTRADIOL; NORGESTIMATE
Dosage form
TABLET
Route
ORAL-28
Marketing status
Prescription
Sponsor
BARR
Manufacturer
Teva Pharmaceuticals USA, Inc.
First approval
2002-09-25

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown